Over 300 Colorado Auctions End Tomorrow 05/12 - Bid Now
Over 150 Total Lots Up For Auction at Two Locations - PA 05/15, NY 05/20

CRYOTHERAPY AND BRACHYTHERAPY WORKSHOPS 2006 by Oncura

by Akane Naka, Project Manager | September 13, 2006
Oncura trains physicians for
Minimally Invasive Treatment Options
The Oncura Story
On July 1, 2003, a merger between two innovative leaders in prostate cancer treatments set the standard for minimally invasive options. The merger between Amersham Health (now GE Healthcare)-Therapy Business, the leader in brachytherapy and Galil Medical's Urology Business, the innovator in cryotherapy procedures was finalized. This formed a new company combining both our people and products enabling us to champion advances in minimally invasive prostate-cancer treatments. This new company is Oncura.

Oncura has a separate and distinct identity from its parent companies and is unique in its ability to offer prostate cancer specialists the two leading minimally invasive treatment options for prostate cancer - brachytherapy and cryotherapy. Having both options in our product portfolio enables us to better meet physicians' and patients' needs.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

Our goal is to champion the appropriate use of brachytherapy and cryotherapy as the treatments of choice for prostate cancer. Brachytherapy has long-term data demonstrating clinical efficacy in treating early stage prostate cancer, while cryotherapy is a suitable minimally invasive treatment option for later-stage or radiation-failure patients. In addition, Oncura has the ability to offer cryotherapy as a minimally invasive option for urologists treating kidney cancer.

Oncura's vision is to lead the market by providing minimally invasive prostate cancer treatment options and to expand our portfolio to include additional products along the prostate disease management continuum.

Forming Oncura exemplifies our ongoing commitment to innovations in minimally invasive prostate and kidney cancer care for patients and physicians.

BRACHYTHERAPY WORKSHOPS 2006

September 25 - 26, 2006
Seattle Prostate Institute
Seattle, WA
Resident's Workshop: "Ultrasound-Guided Transperineal Brachytherapy for Early Stage Prostate Cancer"

September 29 - 30, 2006
New York Prostate Institute
Long Island, NY
Dynamic Brachytherapy for Early Stage Prostate Cancer: The next generation of prostate seed implantation techniques

November 13 - 14, 2006
Seattle Prostate Institute and Swedish Medical Center
Seattle, WA
"Ultrasound Guided Transperineal Brachytherapy for Early Stage Prostate Cancer"

November 20 - 21, 2006
Seattle Prostate Institute
Seattle, WA
Resident's Workshop: "Ultrasound-Guided Transperineal Brachytherapy for Early Stage Prostate Cancer"

December 4 - 5, 2006